Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Jun 2022 13:25

RNS Number : 6012N
Location Sciences Group PLC
01 June 2022
 

1 June 2022

 

Location Sciences Group PLC

("Location Sciences" or the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Location Sciences (AIM: LSAI) announces that it has today been notified of the following transactions by Mr Mark Slade and Mr David Rae, respectively Chief Executive Officer and Chief Financial Officer of the Company.

On 1 June 2022, Mr Mark Slade sold 4,444,444 ordinary shares of 0.1 pence each in the Company ("Shares") at a price of 0.19p per share and Mr David Rae sold 666,667 Shares at a price of 0.22p per share. These transactions were undertaken for tax reasons.

 

Following these share sales, Mr Mark Slade's total shareholding in the Company is 21,760,000 Shares, representing 0.84% of the issued ordinary share capital of the Company and Mr David Rae's total shareholding in the Company is 13,000,000 Shares, representing 0.50% of the issued ordinary share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Slade

2. 

Reason for the Notification

a)

Position/status

Executive Director - Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Location Sciences Group PLC

b)

LEI

213800MKYV25HW2IAX70

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of GBP0.001

 

Identification code

ISIN: GB00BGT36S19

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.19p

4,444,444

 

d)

Aggregated information:

- Aggregated volume

4,444,444

- Price

0.19p

e)

Date of the transaction

1 June 2022

f)

Place of the transaction

Outside a trading venue

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Rae

2. 

Reason for the Notification

a)

Position/status

Executive Director - Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Location Sciences Group PLC

b)

LEI

213800MKYV25HW2IAX70

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of GBP0.001

 

Identification code

ISIN: GB00BGT36S19

b)

Nature of the transaction

Share sale

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.22p

666,667

 

d)

Aggregated information:

- Aggregated volume

666,667

- Price

0.22p

e)

Date of the transaction

1 June 2022

f)

Place of the transaction

Outside a trading venue

 

For further information please contact:

 

Location Sciences Group PLC via Allenby Capital

 

Simon Wilkinson, Chairman

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

Vivek Bhardwaj

 

Turner Pope Investments (TPI) Ltd (Broker) Tel: +44 (0)20 3657 0050

James Pope

Andy Thacker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSLFEFEESEEM
Date   Source Headline
18th Sep 20177:00 amRNSHalf-year Report and Trading Update
14th Sep 20176:03 pmRNSTR-1: Notification of major holdings
13th Sep 201712:40 pmRNSTR-1: Notification of major holdings
11th Sep 20177:00 amRNSLaunch of Location Sciences
6th Sep 20174:59 pmRNSTR-1: Notification of major holdings
5th Sep 20172:49 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNew Directorship
25th Aug 20171:31 pmRNSTR-1: Notification of major holdings
24th Aug 20171:17 pmRNSTR-1: Notification of major holdings
10th Aug 20177:00 amRNSSettlement of credit facility and loan note
9th Aug 20173:00 pmRNSTR-1: Notification of major holdings
28th Jul 20173:43 pmRNSTR-1: Notification of major holdings
27th Jul 20174:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
24th Jul 201711:54 amRNSResult of AGM and GM
24th Jul 20177:01 amRNSAGM Statement
24th Jul 20177:00 amRNSResult of Open Offer
17th Jul 20177:00 amRNSProxama signs agreement with Rail Delivery Group
13th Jul 20177:00 amRNSContract Renewal
3rd Jul 20176:01 pmRNSHolding(s) in Company
30th Jun 201711:31 amRNSResult of Placing
30th Jun 20177:01 amRNSProposed Placing
30th Jun 20177:00 amRNSFinal Results
25th May 20177:00 amRNSNew Contracts
18th May 20177:00 amRNSBoard Changes
17th May 20177:00 amRNSConclusion of the Strategic Review
27th Apr 20171:07 pmRNSNotification of Interest In Shares
28th Mar 20172:04 pmRNSIssue of Equity and Total Voting Rights
7th Mar 20177:00 amRNSDirector Declaration
1st Mar 20174:39 pmRNSResult of General Meeting
1st Mar 20177:00 amRNSNew Contract Win
16th Feb 20177:00 amRNSAppointment of Non-Executive Chairman
13th Feb 20177:00 amRNSPosting of Circular and Notice of General Meeting
9th Feb 20173:40 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Contract Win
3rd Feb 20177:00 amRNSIssue of Equity
23rd Jan 20177:00 amRNSNew Partnership
10th Jan 20177:00 amRNSBeacon network expansion
5th Jan 201710:20 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing
21st Dec 20167:00 amRNSNew Contract
13th Dec 20167:00 amRNSTrading and Funding update
25th Nov 20167:00 amRNS'Santa Forgot' campaign for Alzheimer's Research
29th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20162:55 pmRNSHolding(s) in Company
22nd Sep 20165:22 pmRNSExercise of Options
22nd Sep 20167:00 amRNSNew Contract
2nd Sep 20167:00 amRNSGoogle Certification
11th Aug 20163:24 pmRNSTR-1 Notification of Major Interest in Shares
11th Aug 20163:20 pmRNSDirector/PDMR Shareholding
27th Jul 20164:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.